In summary, our research indicates that age-related elevation of O-GlcNAcylation in the testis disturbs key processes in meiosis and thereby contributes to the impairment of spermatogenesis and infertility. Mimicking the age-related elevation of O-GlcNAcylation by targeting OGA impairs synapsis and DSB repair and further leads to pachytene arrest in young mice. Additionally, disrupting the O-GlcNAc cycle can partially rescue subfertility in aged mice, which provides a potential target for the restoration of fertility. Ultimately, our research highlights O-GlcNAcylation as a new metabolic-coupled PTM mechanism in the regulation of meiosis and a key mediator of age-related subfertility.
Male reproductive aging and infertility have been deeply discussed over the past several decades. A retrospective study of 4822 semen analyses reported that sperm concentration declines after 40 years of age (26). Although only one sperm is necessary for conception, a decline in sperm concentration does affect fertility. The time to conceive for fathers over the age of 45 is approximately 5-fold longer than that for young fathers (27). The deterioration of sperm production during aging can be attributed to the impairment of testicular histological architecture, presented as thinning of the seminiferous epithelium, reduced vascularization of the testes and narrowing of the tubules (28). In a morphometric study, young and old men had similar numbers of A and B spermatogonia per gram of testicular parenchyma, while the transition of early primary to late primary spermatocytes was not as efficient in older men (29). A more recent study reported that the paring, synapsis and recombination of prophase spermatocytes are affected by age in mice. Moreover, in aged mice, spermatocytes with meiotic errors are eliminated by the cell cycle checkpoint, which likely results in reduced sperm production due to germ cell loss (30). Although the conclusions from different studies are not wholly uniform, they all suggest that meiotic errors in aged testes cannot be ignored. In the current study, we demonstrate that spermatogenesis is impaired in aged testes and that meiosis is partially arrested at the pachytene stage. Furthermore, DSBs are not fully repaired in pachytene. These results were consistent with those of a previous study in which an elevation of DSBs was observed in multiple tissues and cells of aged mice, including spermatocytes (31). Similarly, another study reported that aged mice showed increased expression of γH2Ax in the testis, accompanied by activation of the ATM-CHK2 and ATR-CHK1 pathways, which activated p53 and led to cell cycle arrest (31). Cumulatively, these studies and our results suggest that the elevation of DSBs may be one mechanism that causes meiotic arrest and germ cell loss in aged mice.
A previous study reported that the levels of O-GlcNAcylation in various tissues increased during aging, including the brain, lung, skin and thymus (32). In our study, remarkable O-GlcNAcylation increases and OGA decreases were observed in the testes during aging. Thus, the elevation of O-GlcNAc might be a multisystem phenomenon. Mimicking high O-GlcNAcylation in mice impairs spermatogenesis. Analogous to our findings, the involvement of O-GlcNAc and OGA in regulating oocyte development was also reported in previous studies (33). Under hyperglycemic conditions, the developmental competence of mouse oocytes was impaired by the O-GlcNAcylation of HSP90 (33). Moreover, elevation of O-GlcNAcylation by OGA disruption leads to mitotic defects, including cytokinesis failure, lagging chromosomes and binucleation, in embryos (32). Our results are consistent with these studies, providing further evidence that maintaining O-GlcNAc homeostasis is important for the cell cycle, in both mitosis and meiosis.
O-GlcNAc exhibits specialized localization in differentiating spermatogonia and spermatocytes, which are the cells that are undergoing meiotic initiation and progression. Therefore, we focused particularly on its role in meiosis. During the leptotene phase of meiosis, DSBs are induced by SPO11, a meiosis-specific endonuclease (34); DSBs are then repaired during zygotene through homologous recombination, which promotes synapsis and paring. At pachytene, DSBs are fully repaired, and synapsis is fully completed. In our study, elevation of O-GlcNAc led to synapsis and recombination defects, which induced pachytene arrest and germ cell loss. The colocalization of O-GlcNAc and OGA with SYCP3 indicates the possible role of O-GlcNAc in synapsis. These data further confirm that meiosis is regulated by O-GlcNAc. Nevertheless, although diverse proteins participating in multiple biological processes are reported to be regulated by O-GlcNAcylation, there has been no detailed investigation of O-GlcNAcylated proteins involved in meiosis. We reviewed the available O-GlcNAcylation data for crucial meiosis-related proteins (35) and present this information in Table S1. However, most of these proteins were identified in mass spectrometry studies without experimental validation. MDC1, EWSR1, KAT5, SIRT1 and TDP-43 were validated to be O-GlcNAcylated by experiments, but their precise functions in meiosis remain elusive. In this study, we identified one O-GlcNAcylated meiotic protein, REC8, which O-GlcNAcylated level was elevated and protein level was decreased in old mice compared with young mice. Whether O-GlcNAcylation of REC8 influences the protein level and how O-GlcNAcylated REC8 participate in meiosis still need further exploration. Further investigation into protein O-GlcNAcylation in meiosis will broaden our understanding of the PTM landscape in this process.
The elevation of O-GlcNAcylation in young mice produces spermatogenetic defects mimicking those in aged mice, which prompts us to consider O-GlcNAc as a therapeutic target for restoration of fertility. It is the most appropriate choice to restore OGA in aged mice, as OGA decreases with age in the testis. However, an OGA-selective activator has not yet been developed (36). As an alternative, we used OSMI-1, which is an effective OGT inhibitor, to balance O-GlcNAc homeostasis in aged testes. Although OSMI-1 didn’t rescue the sperm parameters in aged mice, it increased the testis size and weight, also promoted meiotic progression. The restorative effects of OSMI-1 in spermatogenesis provide a new potential therapy for reproductive aging. In addition, the therapeutic effects of other OGT inhibitors and HBP inhibitors need further exploration. In conclusion, our study provides new insight into how O-GlcNAcylation participates in age-related spermatogenic disorders and suggests a new target for improving male infertility during aging.